Evidence map›Paper›PMID 38338484›Full record

ArticleMolecules (Basel, Switzerland)2024

Multiscale Modeling of Macromolecular Interactions between Tau-Amylin Oligomers and Asymmetric Lipid Nanodomains That Link Alzheimer's and Diabetic Diseases.

Natalia Santos, Luthary Segura, Amber Lewis, Thuong Pham, Kwan H Cheng

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Natalia SantosNeuroscience Department, Trinity University, San Antonio, TX 78212, USA.
Luthary SeguraNeuroscience Department, Trinity University, San Antonio, TX 78212, USA.
Amber LewisNeuroscience Department, Trinity University, San Antonio, TX 78212, USA.
Thuong PhamPhysics Department, Trinity University, San Antonio, TX 78212, USA.
Kwan H ChengNeuroscience Department, Trinity University, San Antonio, TX 78212, USA.ORCID 0000-0001-8128-6079
Trinity University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular events of protein misfolding and self-aggregation of tau and amylin are associated with the progression of Alzheimer's and diabetes, respectively. Recent studies suggest that tau and amylin can form hetero-tau-amylin oligomers. Those hetero-oligomers are more neurotoxic than homo-tau oligomers. So far, the detailed interactions between the hetero-oligomers and the neuronal membrane are unknown. Using multiscale MD simulations, the lipid binding and protein folding behaviors of hetero-oligomers on asymmetric lipid nanodomains or raft membranes were examined. Our raft membranes contain phase-separated phosphatidylcholine (PC), cholesterol, and anionic phosphatidylserine (PS) or ganglioside (GM1) in one leaflet of the lipid bilayer. The hetero-oligomers bound more strongly to the PS and GM1 than other lipids via the hydrophobic and hydrophilic interactions, respectively, in the raft membranes. The hetero-tetramer disrupted the acyl chain orders of both PC and PS in the PS-containing raft membrane, but only the GM1 in the GM1-containing raft membrane as effectively as the homo-tau-tetramer. We discovered that the alpha-helical content in the heterodimer was greater than the sum of alpha-helical contents from isolated tau and amylin monomers on both raft membranes, indicative of a synergetic effect of tau-amylin interactions in surface-induced protein folding. Our results provide new molecular insights into understanding the cross-talk between Alzheimer's and diabetes.

Indexed as

Alzheimer DiseaseDiabetes MellitusAmyloid beta-PeptidesG(M1) GangliosideHumansIslet Amyloid PolypeptideLipid BilayersPhosphatidylcholinesAmyloid beta-PeptidesG(M1) GangliosideIslet Amyloid PolypeptideLipid BilayersPhosphatidylcholinesAlzheimer’s and diabetics crosstalkamyloid-raft structuresanionic lipid nanodomainslipid raftneuronal membrane leafletsoligomersprotein foldingprotein-lipid binding

Identifiers

PMID38338484
PMCPMC10856442
OpenAlexW4391565958

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.